Their targeted gene was SLC20A2 whose mutations cause the familial idiopathic basal ganglia calcification (Fahr’s disease) molecularly demonstrated as deposits of calcium in basal ganglia and other distinct brain regions. This evidence concerns the gene SLC20A2 and bilateral striopallidodentate calcinosis.